Gastric Bypass and Gallstones: Prevention & Management After Bariatric Surgery

Why rapid weight loss causes gallstones – incidence and timing

Bariatric surgery – particularly Roux‑en‑Y gastric bypass (RYGB) and sleeve gastrectomy – induces rapid weight loss. This dramatic metabolic change is a well‑established risk factor for cholesterol gallstone formation.

• Incidence: 10‑30% of patients develop gallstones within 6‑18 months after surgery. Without prophylaxis, up to 30‑40% develop biliary sludge or stones.
• Timing: Most stones form during the active weight loss phase (first 3‑12 months). After weight stabilises, the risk declines.
• Symptomatic stones: About 5‑15% of those with stones become symptomatic (biliary colic, cholecystitis, pancreatitis).

Mechanisms: biliary sludge, cholesterol supersaturation, gallbladder stasis

Several factors converge to promote lithogenesis post‑bariatric surgery:

• Rapid weight loss: Mobilisation of cholesterol from adipose tissue increases hepatic cholesterol secretion into bile, leading to cholesterol supersaturation.
• Reduced dietary fat intake: Low fat intake decreases cholecystokinin (CCK) release, resulting in infrequent and incomplete gallbladder emptying – biliary stasis.
• Prolonged fasting: Post‑operative dietary restrictions and reduced meal frequency exacerbate stasis.
• Altered bile acid metabolism: RYGB changes the enterohepatic circulation of bile acids, reducing the bile acid pool and further increasing lithogenic index.
• Mucin hypersecretion: The gallbladder mucosa may secrete excess mucin, promoting crystal nucleation.

Sludge (microlithiasis) appears first, which can evolve into frank stones. Once stones form, they are typically cholesterol stones.

Risk factors – who is most likely to develop stones

Not all bariatric patients develop gallstones. Predictors include:

• Greater total weight loss and faster rate of loss.
• Female gender (higher baseline risk).
• Pre‑existing biliary sludge or microlithiasis (detected on pre‑op ultrasound).
• Family history of gallstones.
• Higher pre‑operative BMI.
• Roux‑en‑Y gastric bypass vs. sleeve gastrectomy – RYGB may have slightly higher risk due to more profound metabolic changes (though data mixed).
• Low post‑operative fat intake.

Patients with these risk factors should be considered for prophylactic therapy (see below).

UDCA for prevention – evidence, dosing, and guidelines

Ursodeoxycholic acid (UDCA) is the only proven pharmacologic prophylaxis for post‑bariatric gallstones. Multiple RCTs and meta‑analyses support its use.

• Evidence: A 2020 meta‑analysis (11 RCTs, n=1,246) showed UDCA reduces gallstone formation by ~80% (relative risk 0.20; number needed to treat = 6).
• Dosing: 500‑600 mg/day (or 10‑15 mg/kg/day) for 6 months after surgery. Some studies used 300 mg twice daily. Starting within 2 weeks post‑op is effective.
• Guidelines: The American Society for Metabolic and Bariatric Surgery (ASMBS) and European guidelines recommend UDCA for 6 months after bariatric surgery in all patients without pre‑existing cholelithiasis (grade A evidence).
• Side effects: Mild diarrhoea (5‑10%); generally well‑tolerated.
• Cost‑effectiveness: UDCA is cost‑saving by reducing cholecystectomy and complications.

Prophylactic cholecystectomy during bariatric surgery – pros and cons

Simultaneous cholecystectomy (at the time of bariatric surgery) is controversial. The decision depends on pre‑operative gallbladder status.

• If asymptomatic gallstones are present pre‑operatively: Many surgeons recommend concomitant cholecystectomy. Rationale: these patients are at high risk of symptomatic stones post‑op; performing cholecystectomy during bariatric surgery avoids a second operation.
• If no gallstones: Routine prophylactic cholecystectomy is NOT recommended. It adds operative time, risk of bile duct injury, and does not prevent all stones (stones can form after cholecystectomy in the bile ducts, though rare). UDCA is preferred.
• Incidental cholecystectomy: If the gallbladder is easily accessible and the patient desires it, some surgeons perform it, but evidence does not support routine practice.
• Technical considerations: Cholecystectomy during bariatric surgery is safe, but adhesions from previous surgery or obesity may increase difficulty. The cystic duct and artery are often more challenging due to fatty hilum.

A pragmatic approach: Pre‑operative ultrasound for all bariatric candidates. If stones present, perform cholecystectomy simultaneously. If no stones, prescribe UDCA for 6 months post‑op.

Managing symptomatic gallstones after gastric bypass

If a patient develops symptomatic gallstones post‑bariatric surgery, management depends on symptoms and anatomy:

• Biliary colic (mild): Trial of UDCA (if not already on it) and dietary modification. However, definitive treatment is cholecystectomy.
• Acute cholecystitis: Laparoscopic cholecystectomy is the standard. Technical difficulty is increased due to adhesions, altered anatomy (Roux limb), and intra‑abdominal fat. Experienced bariatric surgeon should perform it.
• Choledocholithiasis (common bile duct stones): ERCP is challenging after RYGB because the papilla is inaccessible via standard gastroscope (the stomach is divided, and the Roux limb is long). Options:
  • Laparoscopic‑assisted ERCP: Surgeon passes an endoscope through the Roux limb or creates a gastrostomy to access the excluded stomach.
  • Enteroscopy‑assisted ERCP: Using a balloon‑assisted enteroscope (single‑ or double‑balloon) to reach the papilla. Success rate 70‑80%, but requires expertise.
  • Percutaneous transhepatic cholangiography (PTC) with stone removal or antegrade sphincterotomy.
  • Laparoscopic common bile duct exploration.

Special considerations: Roux‑en‑Y vs. sleeve, ERCP challenges

• Sleeve gastrectomy: The anatomy is not altered (stomach remains intact but reduced). ERCP is technically normal (no change). Gallstone risk is similar to RYGB, but management of CBD stones is easier.
• Roux‑en‑Y gastric bypass: The excluded stomach and long Roux limb make ERCP difficult. This is a major consideration. Some bariatric surgeons leave a gastrostomy tube or a “gastric remnant access” port for future ERCP, but this is not routine.
• Laparoscopic cholecystectomy after RYGB: Adhesions from the prior surgery and the Roux limb near the gallbladder can make dissection hazardous. Conversion to open is more common.
• Risk of post‑cholecystectomy diarrhoea: Bariatric patients already have altered bowel habits; cholecystectomy may exacerbate diarrhoea due to continuous bile flow.

Given these complexities, prevention is far better than treatment. UDCA prophylaxis should be strongly encouraged.

Interactive FAQ – Gastric bypass and gallstones

Disclaimer: This information is for educational purposes. Bariatric patients should receive pre‑operative ultrasound and post‑operative UDCA per guidelines. Management of gallstones after gastric bypass requires specialised expertise. Consult a bariatric surgeon at Vivekananda Hospital.